In conclusion, primary prostate cancer can be separated into subgroups of clinical significance simply by PSA and Ki67 immunostaining, probably because this combination separates tumors in relation to cell differentiation and cell proliferation. The gene discussed is MKI67; the disease is prostate carcinoma.